Welcome to our dedicated page for Kimball Electronics news (Ticker: KE), a resource for investors and traders seeking the latest updates and insights on Kimball Electronics stock.
Kimball Electronics, Inc. (Nasdaq: KE) generates a steady flow of corporate, financial, and strategic news as a global manufacturer providing Electronics Manufacturing Services (EMS) and Contract Manufacturing Organization (CMO) solutions. From its headquarters in Jasper, Indiana, and operations in the United States, China, Mexico, Poland, Romania, and Thailand, the company reports developments related to its automotive, medical, and industrial vertical markets.
News for KE commonly includes quarterly and annual earnings releases, where Kimball Electronics discusses net sales by vertical market, operating income, adjusted operating income, cash generation from operations, and portfolio changes such as the divestiture of its Automation, Test, and Measurement business. These updates often highlight trends in automotive programs like electronic power steering, body controls, advanced driver-assistance or automated driver assist systems, and electronic braking systems, as well as medical programs in areas such as sleep therapy and respiratory care, guided therapy, in vitro diagnostics, drug delivery, AED, and patient monitoring.
Investors and observers can also expect news about strategic initiatives and capacity investments. The company has announced a new medical CMO facility in Indianapolis, describing it as a significant step in its medical strategy, and later detailed a ribbon-cutting event for an advanced medical manufacturing and innovation hub serving the medical and life sciences industries. Kimball Electronics has also communicated its intention to rebrand as Kimball Solutions, subject to approvals, reflecting what it describes as an expanded portfolio of capabilities and a solutions-driven approach.
Additional news items include participation in investor and industry conferences, announcements of annual meeting dates and proxy-related information, and leadership or governance updates reported through press releases and current reports on Form 8-K. For users following KE, this news stream provides context on the company’s operational performance, strategic focus on medical CMO activities, and its ongoing evolution within the EMS and manufacturing landscape.
Kimball Electronics (Nasdaq: KE) reported Q3 fiscal 2026 results: net sales $352.9M, sequential revenue +3.4%, medical sales +10.2% sequentially. Operating income was $11.8M (3.3% of sales) and adjusted operating margin was 4.2%. Cash from operations was $14.9M, the ninth consecutive quarter of positive operating cash generation. Debt totaled $163.0M; the company repurchased 165,000 shares for $4.0M. The company affirmed fiscal 2026 guidance: net sales $1,400–$1,460M, adjusted operating income 4.2%–4.5% (expected at the high end), and capex $50–$60M.
Kimball Electronics (Nasdaq: KE) will report third quarter fiscal 2026 results on Tuesday, May 5, 2026 after market close. The company will host a conference call and live webcast on Wednesday, May 6, 2026 at 10:00 a.m. ET.
Investors can access the call by phone or via a live webcast at investors.kimballelectronics.com; a replay will be archived there.
Kimball Electronics (Nasdaq: KE) released its 2025 Guiding Principles Report on March 19, 2026, featuring the company’s annual sustainability disclosures under the theme "Building Tomorrow, Together."
The Report outlines progress on environmental, social, and governance (ESG) initiatives and emphasizes areas where the company aims to make lasting impact while supporting long-term business success.
Kimball Electronics (Nasdaq: KE) will participate in multiple investor conferences in March 2026, offering fireside chats and one-on-one meetings with institutional investors.
Events include Cantor Global Technology & Industrial Growth Conference in New York on March 11 (in-person fireside chat 2:10–2:40 p.m. ET), KeyBanc Healthcare Forum virtual chat on March 18 (9:00–9:35 a.m. ET, webcast available), and Roth Conference meetings March 23–24 in Dana Point, CA.
Kimball Electronics (Nasdaq: KE) reported Q2 FY2026 results: net sales $341.3M (down 5% YoY) with medical vertical sales +15% YoY. Operating income was $10.8M (3.2% of sales) and adjusted operating income was 4.5%. Cash from operations was $6.9M, the eighth consecutive positive quarter. The company raised fiscal 2026 guidance to $1.40–$1.46B in net sales and adjusted operating income 4.2%–4.5%. Capital expenditures guidance remains $50–$60M.
Kimball Electronics (Nasdaq: KE) will report second quarter fiscal 2026 financial results on Wednesday, February 4, 2026 after market close. The company will host a conference call and live webcast to review results on Thursday, February 5, 2026 at 10:00 a.m. Eastern Time. Participants can join by phone at 877-407-8293 or +1 201-689-8349, and the live webcast and replay will be available at investors.kimballelectronics.com.
Kimball Electronics (Nasdaq: KE) announced a ribbon-cutting for its new medical manufacturing facility in Indianapolis on February 6, 2026 at 10:00 AM ET (doors 9:30 AM) at 1220 Post Road. Media and community members are invited.
The company also announced an intended rebrand to Kimball Solutions, celebrating 65 years; a phased rollout for subsidiaries begins in July 2026, and the parent entity intends a name change to Kimball Solutions, Inc. subject to share owner and local approvals.
Kimball Electronics (Nasdaq: KE) announced an internal leadership appointment and confirmed participation at the Piper Sandler 37th Annual Healthcare Conference on December 2-4, 2025 in New York. Andrew D. Regrut, currently Treasurer and Investor Relations Officer, will also lead the company’s strategic development efforts and will report to Chief Financial Officer Jana T. Croom as a Section 16 officer.
Management said Regrut contributed to optimizing debt through working capital management and global cash movement. Kimball indicated Jana Croom, Andrew Regrut, and Michael Morales will attend the conference.
Kimball Electronics (Nasdaq: KE) will participate in the 7th Annual Wolfe Research Healthcare Conference held November 17-19, 2025 in New York.
CEO Richard D. Phillips and CFO Jana T. Croom will present on Tuesday, November 18, 2025 at 10:40 a.m. ET. A live webcast and an archived replay will be available on the company's Investor Relations Events & Presentations page at investors.kimballelectronics.com/events-and-presentations/events. Company executives will also be available for one-on-one meetings during the conference.
Kimball Electronics (Nasdaq: KE) reported Q1 FY2026 results for the quarter ended September 30, 2025: net sales $365.6M, operating income $14.5M (4.0% of sales), and adjusted operating income $17.5M (4.8%).
Net income was $10.1M, or $0.40 diluted EPS, with adjusted EPS $0.49—more than double Q1 FY2025. Cash from operations was $8.1M (seventh consecutive quarter positive); debt fell to $138.0M (down $9.5M); Cash Conversion Days improved to 83, the lowest in three years. The company reiterated FY2026 guidance: net sales $1.35B–$1.45B, adjusted operating income 4.0%–4.25%, and capex $50M–$60M.